Nadine Girard Selected Research

syndromic 5 X-linked Mental retardation

3/2014

AP1S2 is mutated in X-linked Dandy-Walker malformation with intellectual disability, basal ganglia disease and seizures (Pettigrew syndrome).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadine Girard Research Topics

Disease

4	Essential Tremor (Essential Tremors) 05/2019 - 11/2017
3	Tremor (Tremors) 01/2021 - 09/2018
3	Neoplasms (Cancer) 05/2019 - 04/2016
2	Glioma (Gliomas) 01/2017 - 01/2012
2	Alzheimer Disease (Alzheimer's Disease) 12/2016 - 09/2015
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Phenylketonurias (Phenylketonuria) 01/2021
1	Craniocerebral Trauma (Head Injury) 02/2020
1	Motor Skills Disorders (Motor Skills Disorder) 01/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Dyslexia (Alexia) 01/2020
1	Combined Pituitary Hormone Deficiency 11/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Prodromal Symptoms 12/2016
1	Cerebral Cortical Thinning 12/2016
1	Dementia (Dementias) 12/2016
1	Brain Diseases (Brain Disorder) 04/2016
1	Atrophy 09/2015
1	Adenoma (Adenomas) 04/2015
1	Acromegaly 04/2015
1	Autism Spectrum Disorder 08/2014
1	Stroke (Strokes) 03/2014
1	syndromic 5 X-linked Mental retardation 03/2014
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 07/2012
1	Seizures (Absence Seizure) 01/2012
1	Temporal Lobe Epilepsy 09/2011
1	Epilepsy (Aura) 09/2011
1	Status Epilepticus (Complex Partial Status Epilepticus) 09/2011
1	Glioblastoma (Glioblastoma Multiforme) 04/2011
1	Drug Resistant Epilepsy 11/2009
1	Focal Cortical Dysplasia 11/2009
1	Edema (Dropsy) 03/2009
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 02/2006
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 02/2006

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2021 - 11/2017
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2017 - 04/2011
2	Donepezil (Aricept)FDA LinkGeneric 12/2016 - 09/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2011 - 03/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2020
1	dicarboxydine (DCD)IBA 01/2020
1	fluorodopa F 18IBA 01/2020
1	Hormones (Hormone)IBA 11/2019
1	VimentinIBA 05/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	Choline (Choline Chloride)IBA 04/2016
1	IronIBA 04/2016
1	Biological ProductsIBA 04/2015
1	CationsIBA 08/2014
1	Amino Acids FDA Link 03/2014
1	Vesicular Transport Adaptor ProteinsIBA 03/2014
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	2,6-dinitrotoluene (DNT)IBA 01/2012
1	Immunoglobulins (Immunoglobulin)IBA 09/2011
1	AntibodiesIBA 09/2011
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2011
1	Vigabatrin FDA Link 03/2009

Therapy/Procedure

4	Deep Brain Stimulation 01/2021 - 11/2017
2	Activities of Daily Living (ADL) 12/2018 - 09/2018
2	Therapeutics 12/2016 - 04/2011
1	Conservative Treatment 01/2022
1	CT protocol 02/2020
1	Time-to-Treatment 03/2014
1	Decompressive Craniectomy 07/2012
1	Electrodes (Electrode) 11/2009
1	Stents 02/2006